Research theme for competitive and other funds (4)：
2024 - 2028 Evaluation study on the regional distribution of pharmacies providing pediatric home health care
2022 - 2026 Development of a GIS-based method for evaluating the accessibility of pharmacy/pharmacist functions, and Generation of proposals for improving uneven distribution
2012 - 2014 Development of similarity measures of "drug names" and "appearance of PTP sheets" for quantitatively evaluating risk of confusion errors
2011 - 2012 投薬ミス防止を目指した医薬品名および外観類似度評価システムの構築
Papers (21)：
Kazuya Nonomura, Kazuya Toyama, Yufu Kondo, Hirofumi Tamaki, Arihiro Osanai, Yoko Ino, Mitsuhiro Nakamura, Kazuhiro Iguchi. Geographical Disparities in the Distribution of Community Pharmacies Providing Aseptic Preparation Services in Japan. Integrated Pharmacy Research and Practice. 2024
Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamura. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. 2024. 16. 8. e68260
Haruka Sagawa, Hayato Kizaki, Kodai Yoshikawa, Tadamasa Kamimura, Shinya Suzuki, Seiichi Hayashi, Hirofumi Tamaki, Hiroki Satoh, Yasufumi Sawada, Satoko Hori. Analyzing the Impact of Drug Name Similarity on Dispensing Errors: An Examination Using a Drug Name Similarity Index. Biological and Pharmaceutical Bulletin. 2024. 47. 8. 1460-1466
Midori Ueyama, Hirofumi Tamaki, Arihiro Osanai, Yoko Ino, Kazuya Nonomura, Mari Iwata, Toshiyuki Matsunaga, Mitsuhiro Nakamura, Kazuhiro Iguchi. Relationship between the Number of Pharmacists per Pharmacy and the Provision of Home Healthcare Services in Japan. YAKUGAKU ZASSHI. 2024. 144. 2. 223-229
Mari Iwata, Mika Maezawa, Koumi Miyasaka, Sakiko Hirofuji, Takaaki Suzuki, Satoshi Nakao, Hirofumi Tamaki, Nanaka Ichihara, Yuka Nokura, Mayuko Masuta, et al. Survey of community and hospital pharmacist involvement in outpatient chemotherapy using Japanese health information data. Journal of Pharmaceutical Policy and Practice. 2024. 17. 1
